Stratrix
On the Record · Bio-rad Laboratories

Bio-rad Laboratories acquisitions, on the record

The businesses Bio-rad Laboratories bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
a small miscellaneous operation from a prior acquisition (Other Operations)
Word for word“Other Operations represent a small miscellaneous operation from a prior acquisition, which was sold during 2023 with no material impact on the consolidated statements of income (loss).” 10-K for 2023
divestitureduring 2023—
Stilla Technologies
Word for word“On February 13, 2025, the Company entered a binding offer to purchase all equity interests in Stilla Technologies (“Stilla”) for approximately $ 225 million in cash, as well as potential future contingent milestone payments for a maximum amount of up to $ 50 million.” 10-K for 2024
agreed acquisitionFebruary 13, 2025approximately $ 225 million in cash
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash received from selling businessesGoodwill from acquisitions
2016-12-31—$100,000
2017-12-31—$26.2 million
2018-12-31$7 million$0
2019-12-31$0$44.3 million
2020-12-31$12.2 million$29.8 million
2021-12-31$0$55.4 million
2022-12-31$1.4 million$55.9 million
2023-12-31$2.5 million$400,000
2024-12-31$0$0
2025-12-31$0$160.5 million

Deal filings since 2016

Read from Bio-rad Laboratories’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-13. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.